Global Interventional Cardiology Devices Market

Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A2171 | Region: Global | Published Date: November, 2025
Pages: 242 |Tables: 67 |Figures: 65

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Interventional Cardiology Devices Market size was valued at USD 14.86 Billion in 2024 and is poised to grow from USD 15.95 Billion in 2025 to USD 28.02 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026–2033).

    Global interventional cardiology devices market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Abbott Laboratories ', 'B. Braun Melsungen AG ', 'Boston Scientific Corporation ', 'Medtronic PLC ', 'Terumo Corporation ', 'Biotronik SE & Co. KG ', 'Biosensors International Group Ltd ', 'ACIST Medical Systems ', 'Cardinal Health, Inc. ', 'Cook Medical Inc. ', 'Koninklijke Philips N.V. ', 'Edwards Lifesciences Corporation ', 'Nano Therapeutics Pvt. Ltd. ', 'AngioDynamics, Inc. ', 'Inari Medical, Inc. ', 'Genetesis, Inc. ', 'OptiMed Medical Instruments GmbH ', 'Meril Life Sciences Pvt. Ltd. ', 'OrbusNeich Medical'

    Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

    Obesity is increasing the prevalence of cardiovascular disease. Furthermore, the incidence of coronary artery disease has increased as a result of changing lifestyles characterised by smoking, heavy alcohol consumption, and inactivity. With the use of interventional cardiology instruments, cardiologists can perform treatments quickly and without causing complications.

    North America is expected to lead the global interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

    Related Reports

    Cardiovascular Devices Market
    Buy Now GET FREE SAMPLE
    Cardiac Assist Devices Market
    Buy Now GET FREE SAMPLE
    Cardiac Rhythm Management Devices Market
    Buy Now GET FREE SAMPLE
    Heart Pump Device Market
    Buy Now GET FREE SAMPLE
    Cardiac Monitoring and Cardiac Rhythm Management Devices Market
    Buy Now GET FREE SAMPLE
    Structural Heart Devices Market
    Buy Now GET FREE SAMPLE
    Neurovascular Devices Market
    Buy Now GET FREE SAMPLE
    Peripheral Vascular Devices Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Interventional Cardiology Devices Market

    Report ID: SQMIG35A2171

    $5,300
    BUY NOW